Psoriatic arthropathies

M13_PSORIARTH

psoriatic arthritis: Joint inflammation associated with psoriasis.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M07.0, M07.0L40.5, M07.1, M07.1L40.5, M07.2, M07.2L40.5, M07.3, M07.3L40.5 Hospital discharge: ICD-9 — 6960 Hospital discharge: ICD-8 — 6960 Cause of death: ICD-10 — M07.0, M07.0L40.5, M07.1, M07.1L40.5, M07.2, M07.2L40.5, M07.3, M07.3L40.5 Cause of death: ICD-9 — 6960 Cause of death: ICD-8 — 6960 2 out of 7 registries used, show all original rules.	4436
4. Check minimum number of events None	4436
5. Include endpoints None	4436
6. Filter based on genotype QC (FinnGen only)	4436

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_PSORIARTH
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M07[0-3]
HD_ICD_9	6960
HD_ICD_8	6960
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M07[0-3]
COD_ICD_9	6960
COD_ICD_8	6960
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Psoriatic arthropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22720	11238	11370
Only index persons	21177	10670	10507
Unadjusted period prevalence (%)
Whole population	0.32	0.32	0.32
Only index persons	0.40	0.39	0.40
Median age at first event (years)
Whole population	50.47	51.66	49.27
Only index persons	50.09	51.30	48.86

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4436	2453	1983
Unadjusted period prevalence (%)	0.85	0.84	0.87
Median age at first event (years)	50.91	50.73	51.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4050: Matched controls
40500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AB04

ATC

adalimumab; parenteral

73.5

323.0

650

105

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

16384.0

323.0

3556

D07XC01

ATC

betamethasone, combinations; topical

17.3

323.0

2039

2239

D05AX52

ATC

calcipotriol, combinations; topical

44.8

323.0

1933

808

E000001

ATC

5.3

323.0

1583

4384

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

211.1

323.0

2992

534

H02AB06

ATC

prednisolone; systemic

5.5

323.0

2695

10799

L88

ICPC

Rheumatoid/seropositive arthritis

81.5

323.0

758

114

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

118.2

323.0

1628

229

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

165.5

323.0

932

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

13.5

323.0

679

595

D07AC01

ATC

betamethasone; topical

6.6

323.0

2555

8312

D05BB02

ATC

acitretin; oral

26.8

323.0

585

253

E0000UV

ATC

5.1

323.0

2498

9750

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

195.0

323.0

3103

672

P01BA02

ATC

hydroxychloroquine; oral

22.4

323.0

719

387

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

216.4

323.0

1246

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

943.5

323.0

346

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

14.5

323.0

998

892

D07AC13

ATC

mometasone; topical

4.2

323.0

1905

7037

A07EC01

ATC

sulfasalazine; oral, rectal

76.6

323.0

1949

484

M07.3

ICD-10 Finland

Other psoriatic arthropathies

6533.2

323.0

1656

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

409.5

323.0

475

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

124.0

323.0

1543

200

L04AA13

ATC

leflunomide; oral

681.0

323.0

776

D05AX03

ATC

calcitriol; topical

46.4

323.0

510

125

L40.5

ICD-10 Finland

Arthropathic psoriasis

1779.1

323.0

2250

M13.9

ICD-10 Finland

Arthritis, unspecified

42.4

323.0

793

231

D07AD01

ATC

clobetasol; topical

7.4

323.0

1562

3173

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

+∞

323.0

376

D05AX02

ATC

calcipotriol; topical

46.4

323.0

1489

501

M17.1

ICD-10 Finland

Other primary gonarthrosis

16.1

323.0

701

521

L40.0

ICD-10 Finland

Psoriasis vulgaris

55.6

323.0

1759

551

L04AB01

ATC

etanercept; parenteral

119.4

323.0

437

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

149.1

323.0

949

M25.5

ICD-10 Finland

Pain in joint

6.2

323.0

1526

3585

M01AH05

ATC

etoricoxib; oral

3.7

320.7

2792

15254

L40

ICD-10 Finland

Psoriasis

26.2

320.1

454

194

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

57.9

315.6

374

S91

ICPC

Psoriasis

60.1

298.9

352

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

12.6

296.3

556

503

L40.9

ICD-10 Finland

Psoriasis, unspecified

30.1

294.2

401

147

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

513.7

292.3

288

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

283.7

269

NH3EA

NOMESCO Finland

Feet X-ray examination with load

99.6

276.7

304

D07AB02

ATC

hydrocortisone butyrate; topical

3.6

269.8

1663

6611

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

89.4

267.7

298

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

84.1

263.8

296

L04AC10

ATC

secukinumab; parenteral

205.6

261.0

269

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

252.9

2074

10063

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

77.0

252.9

287

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

316.6

235.4

237

M19.0

ICD-10 Finland

Primary arthrosis of other joints

22.3

229.4

341

166

M01AH01

ATC

celecoxib; oral (coxibs)

4.3

229.3

994

2845

M01AC06

ATC

meloxicam; systemic, rectal

3.1

228.1

1772

8097

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

190.9

225.7

234

E000002

ATC

4.7

219.2

842

2127

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

+∞

215.5

205

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

11.9

213.9

410

379

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

126.0

200.3

215

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

112.9

197.2

214

E000003

ATC

7.8

194.7

477

679

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

3.2

194.6

1310

5273

L04AA32

ATC

apremilast; oral

337.8

194.2

195

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

1840.3

193.1

186

L40.8

ICD-10 Finland

Other psoriasis

35.6

192.3

251

TNG10

NOMESCO Finland

Puncture of knee

484.6

187.8

186

M16.1

ICD-10 Finland

Other primary coxarthrosis

21.0

187.5

284

145

N02AX02

ATC

tramadol; systemic, rectal

2.7

179.7

1777

9069

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

29.4

178.4

244

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

174.4

1457

6676

L04AC13

ATC

ixekizumab; parenteral

581.8

170.5

168

L04AB06

ATC

golimumab; parenteral

65.0

170.2

198

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

24.5

166.6

240

104

L04AD01

ATC

ciclosporin; systemic

15.2

164.5

281

198

M01CB01

ATC

sodium aurothiomalate; parenteral

289.5

163.9

166

D05AA

ATC

Tars

37.0

163.3

211

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

19.3

156.9

244

134

M01AE02

ATC

naproxen; oral, rectal

2.4

154.0

2410

15326

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.5

152.7

1919

10879

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

114.6

152.3

165

L04AA01

ATC

[U] ciclosporin; systemic

24.1

150.0

217

NG1DA

NOMESCO Finland

X-ray of knees

77.2

149.8

170

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

509.5

149.5

148

M01CB03

ATC

auranofin; oral

220.8

144.9

149

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

144.6

138

D02AE01

ATC

carbamide; topical

5.0

141.0

498

1115

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

72.7

140.8

161

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

57.2

139.1

165

A02BC02

ATC

pantoprazole; systemic

2.3

138.0

2642

18091

H02AB07

ATC

prednisone; oral

3.4

135.8

746

2494

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

13.0

133.8

244

199

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

17.3

133.8

216

131

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

129.9

1703

9611

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.8

128.9

346

552

NF1AA

NOMESCO Finland

Hip X-ray examination

7.2

128.2

330

496

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

18.7

128.0

201

113

L20

ICPC

Joint symptom/complaint NOS

9.6

127.1

271

301

M01AH02

ATC

rofecoxib; oral

3.7

126.5

611

1833

N02BE01

ATC

paracetamol; systemic, rectal

2.7

124.8

3426

27306

D07AB08

ATC

desonide; topical

3.5

121.8

631

2001

ZX140

NOMESCO Finland

Intra articular

123.0

121.8

131

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

14.8

121.8

209

148

J01DB01

ATC

cefalexin; oral

2.5

121.5

3334

26282

N02AJ06

ATC

codeine and paracetamol; systemic

2.3

121.2

1488

8052

L04AC05

ATC

ustekinumab; parenteral

45.8

118.3

146

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

4.4

117.8

467

1168

M45

ICD-10 Finland

Ankylosing spondylitis

10.8

115.6

230

224

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

173.5

112.9

118

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.1

110.3

467

1239

299

Kela drug reimbursment

+∞

109.9

105

134

Kela drug reimbursment

General erythroderma

55.4

108.3

129

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

93.5

106.6

118

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.0

105.5

459

1246

L04AB05

ATC

certolizumab pegol; parenteral

221.8

105.1

108

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

8.7

104.8

236

287

TQW80

NOMESCO Finland

Local dermatologic skincare

8.4

104.0

238

297

WX320

NOMESCO Finland

Spinalanesthesy

2.9

103.8

740

2917

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

13.0

102.7

186

149

M01AB05

ATC

diclofenac; systemic, rectal

2.1

102.4

2691

19765

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

102.0

517

1596

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

1013.1

101.6

L40.4

ICD-10 Finland

Guttate psoriasis

41.6

99.5

125

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

62.2

98.4

115

WZA10

NOMESCO Finland

Long statement of health and health related matters

14.4

98.1

170

123

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

97.3

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

27.3

97.2

135

E000006

ATC

3.9

97.0

436

1215

L04AA11

ATC

[U] etanercept; parenteral

149.4

96.5

102

291

Kela drug reimbursment

Tofacitinib

+∞

95.2

M20.1

ICD-10 Finland

Hallux valgus (acquired)

10.3

94.8

193

196

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

10.9

94.2

186

178

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

52.8

94.1

113

M01AX17

ATC

nimesulide; oral

2.4

93.9

974

4725

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

4.6

92.5

342

791

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

19.1

91.5

142

R4120

NOMESCO Finland

Occupational therapy

4.4

90.6

352

855

L15

ICPC

Knee symptom/complaint

2.8

90.3

672

2701

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.7

89.2

431

1273

M01AX05

ATC

glucosamine; oral

3.0

88.4

562

2038

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

17.0

88.4

143

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

184.0

86.5

J01FF01

ATC

clindamycin; systemic

2.2

86.1

1145

6213

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

50.8

86.1

104

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

845.6

84.9

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

87.5

84.4

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

40.3

83.9

106

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

287.3

82.9

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

42.2

82.4

103

N03AX16

ATC

pregabalin; oral

2.3

82.0

889

4370

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

52.8

81.7

M13.0

ICD-10 Finland

Polyarthritis, unspecified

41.9

81.4

102

M79.6

ICD-10 Finland

Pain in limb

2.1

80.8

1265

7319

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

17.4

78.1

125

M04AA01

ATC

allopurinol; systemic

3.3

77.9

435

1432

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.1

77.8

199

294

H02AB04

ATC

methylprednisolone; systemic

2.6

77.7

639

2706

E000007

ATC

3.9

77.6

340

920

M17.5

ICD-10 Finland

Other secondary gonarthrosis

64.9

76.8

B01AB05

ATC

enoxaparin; parenteral

2.2

76.5

1012

5431

L04AA29

ATC

tofacitinib; oral

95.3

76.2

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

75.2

D05AX05

ATC

tazarotene; topical

72.1

74.5

M02AA07

ATC

piroxicam; topical

2.0

74.1

1321

7986

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

74.1

591

2453

A02BC05

ATC

esomeprazole; systemic

1.9

73.9

1548

9932

M22.4

ICD-10 Finland

Chondromalacia patellae

36.0

73.5

M10.9

ICD-10 Finland

Gout, unspecified

6.3

73.3

205

342

L04AA17

ATC

[U] adalimumab; parenteral

368.8

72.9

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

72.3

1424

8915

212

Kela drug reimbursment

Gout

+∞

72.1

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

43.2

71.6

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.3

71.5

286

711

M01AX01

ATC

nabumetone; oral

5.3

69.3

223

442

M54.5

ICD-10 Finland

Low back pain

2.0

69.1

1218

7289

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

69.0

839

4307

M01AB55

ATC

diclofenac, combinations; oral

4.0

68.8

297

792

SPAT1202

SPAT

Intra-articular injection

8.9

68.4

150

174

R4110

NOMESCO Finland

Physiotherapy

2.1

68.3

1009

5629

3005

Kela drug reimbursment

Tofacitinib

78.6

68.3

Z50.1

ICD-10 Finland

Other physical therapy

4.5

67.9

257

605

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

67.7

976

5387

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

67.7

1148

6760

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

44.5

67.2

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.0

66.7

285

752

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.7

66.7

497

1973

XX9XE

NOMESCO Finland

Other ultrasound examination

21.1

65.0

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.8

64.9

297

832

SPAT1153

SPAT

Removal of sutures

1.9

64.1

1121

6652

NF1DA

NOMESCO Finland

X-ray of hips

23.5

63.8

A46

ICD-10 Finland

Erysipelas

2.6

63.0

528

2240

L90

ICPC

Osteoarthrosis of knee

6.7

62.9

167

260

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

62.9

1046

6083

L17

ICPC

Foot/toe symptom/complaint

2.1

62.5

863

4656

WX111

NOMESCO Finland

Local infiltration anesthesia

165.0

62.1

S18

ICPC

Laceration/cut

1.8

61.9

1444

9457

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

10.6

61.5

122

118

M20.2

ICD-10 Finland

Hallux rigidus

50.2

61.3

A02BC03

ATC

lansoprazole; oral

1.9

60.9

1083

6442

ZXA00

NOMESCO Finland

Right side

2.0

60.6

890

4916

J01AA02

ATC

doxycycline; systemic

1.8

60.0

3019

25008

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

13.6

59.7

105

ZXA05

NOMESCO Finland

Left side

2.1

59.7

832

4494

N03AX12

ATC

gabapentin; oral

2.4

59.5

556

2496

J01DA01

ATC

[U] cefalexin; systemic

1.7

59.5

2403

18569

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

59.3

1484

9906

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

16.0

59.0

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

202.9

58.2

M19.2

ICD-10 Finland

Other secondary arthrosis

106.6

58.0

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

53.9

57.9

D02AX

ATC

Other emollients and protectives

4.8

57.7

201

434

D07XB01

ATC

flumetasone, combinations; topical

16.3

57.5

D07BC01

ATC

betamethasone and antiseptics; topical

2.4

57.4

545

2463

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

57.3

319

1041

D07AA02

ATC

hydrocortisone; topical

2.3

57.2

578

2694

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

123.8

56.9

M13.8

ICD-10 Finland

Other specified arthritis

28.6

55.8

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

45.3

54.6

M79.7

ICD-10 Finland

Fibromyalgia

5.6

54.2

165

306

M48.0

ICD-10 Finland

Spinal stenosis

2.8

54.0

383

1468

L04AC16

ATC

guselkumab; systemic

87.0

54.0

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

33.9

53.6

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.3

53.2

285

903

M03BX02

ATC

tizanidine; oral

1.7

53.0

2386

18711

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.2

52.0

206

506

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

84.1

52.0

J01FA10

ATC

azithromycin; systemic

1.7

51.6

2188

16813

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

51.1

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

50.9

2001

15036

L99

ICPC

Musculoskeletal disease other

7.9

50.9

119

154

M01AB01

ATC

indometacin; systemic, rectal

3.2

50.6

288

953

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.3

50.4

536

2551

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

50.1

B01AF01

ATC

rivaroxaban; oral

2.9

49.7

324

1174

A02BC01

ATC

omeprazole; systemic

1.9

49.7

956

5779

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.0

49.3

308

1085

R03AC02

ATC

salbutamol; inhalant

1.6

49.2

1908

14236

M07.2

ICD-10 Finland

Psoriatic spondylitis

+∞

49.0

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

+∞

49.0

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

7.5

49.0

119

163

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

49.0

1428

9834

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

48.2

2662

21775

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

+∞

48.0

WZA90

NOMESCO Finland

Other doctors statement

1.9

47.8

833

4854

L13

ICPC

Hip symptom/complaint

2.4

47.7

428

1868

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

47.5

3516

31326

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

473.1

47.4

J01FA06

ATC

roxithromycin; oral

1.7

47.4

1495

10499

1220

FHL

Arthroscopy

6.3

46.9

129

211

N06AA09

ATC

amitriptyline; systemic

2.6

46.8

373

1525

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

46.7

892

5361

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

44.4

46.4

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3010144) Erythrocytes [#/volume] in Synovial fluid

211

36.27

307.65

1.7

1.1

e6/l

23643.0

68210.8

0.59

149

(3013115) Eosinophils [#/volume] in Blood

3798

16734

9.83

307.65

13.1

5.4

e9/l

0.2

0.52

3641

14565

(3017181) Myelocytes/100 leukocytes in Blood

1108

2536

5.49

307.65

5.5

4.0

0.5

0.9

2.86

206

744

(3021440) Promyelocytes/100 leukocytes in Blood

1086

2399

5.67

307.65

5.5

4.1

0.0

0.2

1.89

200

698

(3021601) Nitrite [Presence] in Urine by Test strip

2916

15935

3.42

307.65

6.8

4.3

estimate

0.0

0.80

755

2861

(3023420) DNA double strand Ab [Units/volume] in Serum

319

205

16.69

307.65

1.3

1.4

iu/ml

55.7

26.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1898

7861

3.47

307.65

2.8

2.3

umol/l

3640.1

5429.4

1.24

1705

6929

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

269

52.97

307.65

1.9

1.2

39.4

23.9

1.88

165

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

329

54.59

307.65

1.9

1.0

49.7

65.9

1.86

211

(3006315) Basophils [#/volume] in Blood

3765

16096

9.85

307.65

12.8

5.2

e9/l

0.0

10.42

3596

13760

(3009261) Glucose [Presence] in Urine by Test strip

2933

16092

3.43

307.65

5.1

3.1

estimate

0.0

0.22

720

2756

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1693

4004

6.22

307.65

1.4

1.1

u/ml

8.5

2.4

5.11

666

1646

(3002179) Metamyelocytes/100 leukocytes in Blood

1032

2310

5.52

307.65

4.8

3.9

0.3

0.6

2.60

157

538

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1635

4329

5.40

307.65

1.4

1.2

iu/ml

64.3

17.4

1.17

433

1232

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

600

200

34.54

307.65

1.7

1.1

—

(3022096) Basophils/100 leukocytes in Blood

3430

14633

6.93

307.65

13.4

5.4

0.8

0.7

19.56

3354

13642

(3013707) Erythrocyte sedimentation rate by Westergren method

4042

24255

8.50

307.65

9.6

3.1

mm/h

12.2

11.2

4.89

3945

22318

(3044941) Cell count panel - Synovial fluid

325

113

30.96

307.65

1.6

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

1511

3688

5.70

307.65

1.4

1.3

titre

389.1

528.5

2.42

293

700

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

212

32.69

307.65

1.4

2.5

mg/l

8.5

8.8

0.12

161

(3021788) Differential panel - Synovial fluid

414

47.46

307.65

1.7

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

525

159

37.32

307.65

2.0

1.2

e6/l

7235.1

22442.4

1.19

418

104

(3021589) Normoblasts [#/volume] in Blood

2861

15011

3.55

307.65

16.0

8.5

e9/l

0.0

1.82

2630

12104

(3037467) Urinalysis macro (dipstick) panel - Urine

3683

22559

4.73

307.65

6.5

3.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2898

15877

3.38

307.65

5.0

3.1

estimate

0.0

1.08

706

2792

(3002030) Lymphocytes/100 leukocytes in Blood

3482

15724

6.65

307.65

13.6

5.4

29.7

28.1

16.19

3412

14654

(3018010) Neutrophils/100 leukocytes in Blood

3467

15460

6.69

307.65

13.1

5.2

56.0

57.0

6.34

3396

14463

(3013650) Neutrophils [#/volume] in Blood by Automated count

3875

19133

9.11

307.65

15.6

9.2

e9/l

3.9

4.1

6.47

3704

16594

(3001604) Monocytes [#/volume] in Blood

3754

16033

9.73

307.65

12.7

5.1

e9/l

0.6

1.42

3581

13710

(40760892) CBC W Ordered Manual Differential panel - Blood

1969

7343

4.02

307.65

8.0

4.0

—

(42870588) Differential panel, method unspecified - Blood

2849

10474

5.81

307.65

11.1

5.4

—

(3019069) Monocytes/100 leukocytes in Blood

3468

15233

6.85

307.65

13.9

5.6

8.8

8.6

6.58

3395

14284

(3019198) Lymphocytes [#/volume] in Blood

3766

16550

9.45

307.65

13.0

5.2

e9/l

2.0

1.9

1.29

3627

14460

(3025159) Blasts/100 leukocytes in Blood

1063

2271

5.84

307.65

5.5

4.0

0.0

0.2

0.68

175

587

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

883

676

16.06

307.65

1.6

iu/ml

0.5

0.2

0.73

178

132

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4037

26210

7.01

307.65

11.3

7.3

u/l

76.1

77.8

1.98

3967

24686

(3006504) Eosinophils/100 leukocytes in Blood

3464

15129

6.89

307.65

13.4

5.3

2.9

1.02

3390

14090

(3008898) HLA-B27 [Presence]

604

771

8.91

307.65

1.1

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

176

35.89

280.55

1.3

1.9

au/ml

242.2

100.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

838

2348

4.17

266.47

1.2

1.5

—

(3015736) pH of Urine

2294

12198

2.82

247.32

4.5

3.0

—

5.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1056

3639

3.50

246.36

1.3

1.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

362

532

7.32

236.72

3.1

3.2

e9/l

4.0

0.12

362

532

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

364

553

7.08

230.78

3.2

3.6

55.7

57.4

1.35

364

553

(3018095) Leukocytes [#/volume] in Urine

2088

11272

2.61

207.96

4.0

3.3

e6/l

71.5

101.6

0.97

1487

7817

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2318

13249

2.57

203.38

2.5

2.1

nmol/l

76.6

76.9

0.20

2176

12023

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1147

4647

2.98

199.24

1.4

1.6

—

(40758558) Short blood count panel - Blood

1685

8414

2.62

194.28

10.7

7.0

—

(3024263) Appearance of Synovial fluid

126

25.40

179.90

2.5

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1440

7150

2.50

162.55

4.6

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1592

8351

2.41

158.44

5.6

3.4

estimate

0.0

1.85

744

2740

(3015171) Extractable nuclear Ab [Units/volume] in Serum

406

970

4.51

156.02

1.2

u/ml

0.5

0.8

0.44

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2104

12523

2.29

155.11

5.6

3.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4252

35428

5.83

148.62

22.4

11.8

mg/l

16.4

24.5

74.07

3847

26911

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

327

749

4.63

132.07

1.7

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

1268

6438

2.36

131.64

2.7

2.4

e6/l

4.9

6.0

1.86

1140

5601

(3002582) Erythrocytes [#/volume] in Urine

1674

9674

2.17

125.77

3.3

2.9

e6/l

37.9

72.4

1.62

1400

7235

(3041096) Erythrocytes [Presence] in Urine by Automated

1576

8977

2.17

122.07

4.8

2.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1545

8785

2.16

119.73

3.3

2.9

e6/l

0.3

0.5

1.07

1270

6419

(3042936) Bacteria identified in Isolate by Culture

876

3974

2.50

115.07

2.2

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1102

5704

2.24

106.00

1.5

1.8

—

(36304419) Bacteria [Presence] in Urine

1467

8585

2.06

101.99

3.2

2.8

—

(3000494) Fungus identified in Specimen by Culture

822

3869

2.38

98.13

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

12.40

96.87

2.4

2.3

au/ml

156.4

138.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

326

970

3.55

91.24

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

11.13

90.35

2.6

2.8

mg/l

7.1

8.3

0.65

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2267

15960

1.86

86.88

5.9

6.7

mmol/l

1.2

0.04

1914

13491

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

254

660

4.02

86.47

1.1

1.2

—

(3026782) Osmolality of Urine

1111

6196

2.06

85.60

3.0

2.6

mosm/kgh2o

565.9

547.3

1.93

995

5247

(3002385) Erythrocyte distribution width [Ratio]

3654

30223

2.19

84.91

26.7

14.8

13.9

13.6

29.55

3637

29498

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

25.77

80.45

1.6

1.0

45.2

32.9

0.70

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

10.08

80.01

1.4

1.6

ug/l

9.3

8.7

0.51

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3973

34389

2.49

76.73

19.1

11.3

ml/min/173m2

85.9

83.3

13.89

3599

28121

(3007853) Bacteria identified in Skin by Aerobe culture

716

3504

2.24

76.43

2.0

1.7

—

(3019150) Specific gravity of Urine by Refractometry

1147

6729

1.95

75.09

5.7

3.4

kg/l

1.0

1.61

168

959

(3005719) IgG [Mass/volume] in Serum or Plasma

528

2358

2.41

69.37

2.0

2.7

g/l

10.8

10.7

0.22

486

2153

(40768443) Skin Pathology biopsy report

368

1385

2.81

68.70

1.2

—

(3023368) Bacteria identified in Blood by Culture

1312

8242

1.84

68.44

4.4

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

947

5370

1.97

67.54

2.6

e6/l

1.0

1.2

0.56

635

2930

(3031040) Bacteria [#/volume] in Urine by Automated count

2748

21441

1.74

66.14

4.7

3.8

e6/l

1690.5

1405.1

0.14

289

(3017732) Neutrophils [#/volume] in Blood

488

2158

2.42

65.37

3.6

2.8

e9/l

3.9

4.1

1.10

391

1755

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2343

17618

1.70

63.40

5.3

6.8

umol/l

10.6

11.5

2.72

2235

16789

(3024561) Albumin [Mass/volume] in Serum or Plasma

1968

14152

1.70

62.68

4.4

5.0

g/l

35.7

35.8

0.36

1842

13184

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4279

39100

3.67

62.54

23.4

9.0

u/l

29.7

27.4

12.86

4245

37718

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1184

7418

1.81

61.10

2.4

2.1

mg/l

3.1

2.9

2.38

1048

6331

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

131.91

60.99

1.6

2.6

mg/l

1.5

2.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

219

656

3.46

60.36

1.2

1.3

u/ml

14.7

5.2

0.88

115

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

232

728

3.31

59.39

1.2

u/ml

5.0

41.3

—

(3018418) pH of Serum or Plasma

1413

9384

1.74

59.35

3.5

4.0

7.4

0.50

305

1833

(3022948) Iron [Moles/volume] in Serum or Plasma

831

4702

1.94

58.76

2.4

umol/l

12.9

13.7

2.28

781

4369

(3007164) IgA [Mass/volume] in Serum or Plasma

1041

6348

1.84

58.30

1.5

1.4

g/l

2.6

2.4

1.97

667

3968

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

214

648

3.42

57.97

1.2

u/ml

3.4

2.3

0.26

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1964

14331

1.66

57.58

5.2

6.0

mmol/l

1.2

0.09

1829

13003

(40761535) Cells panel - Urine sediment

495

2341

2.25

56.40

4.9

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

709

3865

1.99

55.60

2.4

2.3

ug/g

142.1

141.4

0.01

583

3103

(3045414) Leukocytes [Presence] in Urine

331

1323

2.62

54.65

1.8

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

419

1873

2.37

54.41

1.6

1.9

g/l

1.2

1.4

1.05

383

1712

(3004789) Transferrin [Mass/volume] in Serum or Plasma

768

4333

1.93

54.37

2.4

g/l

2.4

2.3

1.85

718

4026

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

722

4020

1.95

53.05

2.4

2.5

22.2

23.6

1.90

639

3463

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

180

520

3.57

52.41

1.2

u/ml

1.2

1.4

0.43

(3045424) Erythrocytes [Presence] in Urine

176

521

3.48

49.36

1.4

—

(3000330) Specific gravity of Urine by Test strip

355

1539

2.42

49.25

4.4

3.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

234

825

2.94

49.03

1.7

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1380

9490

1.66

48.89

2.1

u/l

150.5

255.9

5.25

1296

8948

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1738

12812

1.59

45.52

2.1

1.8

pmol/l

92.7

95.9

2.22

994

6707

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1074

7048

1.69

44.84

1.7

mg/l

1.1

1.2

0.62

854

5310

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1201

8149

1.65

43.95

2.9

ng/l

1296.0

1195.1

0.34

1022

6966

(3009871) Measles virus Ab [Titer] in Serum

119

6.22

42.87

1.8

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

221

813

2.81

42.78

1.5

g/l

0.2

0.31

212

767

(3013826) Glucose [Moles/volume] in Serum or Plasma

2431

19523

1.54

42.35

4.6

mmol/l

6.7

0.11

2292

18168

(40761536) Microorganisms panel - Urine sediment

516

2762

1.98

41.89

4.4

3.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

172

558

3.17

41.62

1.2

u/ml

38.9

45.9

0.17

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

224

842

2.75

41.62

1.5

g/l

1.2

1.71

216

794

(3032080) INR in Blood by Coagulation assay

1705

12755

1.55

40.50

8.6

8.0

inr

1.2

1.15

583

3826

(3039162) Centromere protein B Ab [Units/volume] in Serum

121

318

3.88

40.45

1.2

1.3

u/ml

99.8

43.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

349

1637

2.23

40.13

2.5

e6/l

0.2

0.3

0.48

341

1592

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

925

6001

1.68

39.66

1.6

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

9.14

39.50

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1024

6861

1.64

38.60

1.6

1.5

nmol/l

20.8

20.2

0.52

903

5924

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1073

7281

1.62

38.41

1.3

1.2

u/ml

1.5

2.1

0.62

299

2008

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

806

5127

1.70

36.92

2.9

2.7

e6/l

2.8

2.6

0.18

495

2696

(3027945) Reticulocytes/100 erythrocytes in Blood

555

3178

1.85

36.48

2.6

2.5

1.8

0.46

499

2834

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1834

14186

1.50

35.93

3.1

2.6

ug/l

136.1

132.6

0.24

1711

13220

(3004588) Protein electrophoresis panel - Serum or Plasma

361

1792

2.10

35.87

1.8

2.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

148

484

3.13

35.35

2.6

3.7

0.9

1.5

1.71

112

378

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1557

11681

1.51

35.15

3.5

3.3

u/l

32.9

36.5

1.63

1471

11099

(3019550) Sodium [Moles/volume] in Serum or Plasma

4022

37068

1.91

34.32

17.4

13.8

mmol/l

139.6

139.7

3.16

3941

36053

(3026008) Bacteria identified in Urine by Culture

1250

8988

1.54

34.20

3.1

2.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1403

10348

1.52

34.09

2.5

2.6

u/l

53.7

58.6

5.02

1298

9594

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

122

363

3.43

33.98

1.6

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4033

37230

1.92

33.83

17.5

13.9

mmol/l

3.9

4.0

1.66

3949

36142

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

477

2680

1.87

33.14

2.9

3.8

mmol/l

1.2

0.08

436

2344

(1761482) Bacteria [#/volume] in Urine by Culture

207

841

2.53

32.88

5.3

3.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

231

988

2.41

32.85

1.2

1.3

titre

100.0

165.1

0.50

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1598

12186

1.49

32.69

3.8

3.1

ng/l

94.9

52.4

0.52

1082

7826

(3020630) Protein [Mass/volume] in Serum or Plasma

426

2320

1.93

32.54

2.0

2.8

g/l

67.7

66.3

3.37

392

2149

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3105

26970

1.50

32.42

4.2

3.8

pmol/l

14.7

0.20

2864

24738

(3013512) EKG study

1277

9316

1.52

32.32

4.2

3.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3661

33018

1.62

31.84

6.3

5.2

mmol/mol

40.0

39.5

1.90

3426

30612

(3019309) Folate [Moles/volume] in Red Blood Cells

803

5285

1.63

31.76

1.8

1.7

nmol/l

1158.5

1140.2

0.22

640

4042

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1868

14785

1.46

31.12

4.3

3.8

—

(3023520) Reticulocytes [#/volume] in Blood

417

2298

1.90

30.67

2.2

2.7

e9/l

73.4

71.2

0.47

313

1723

(3036481) Cortisol [Moles/volume] in Serum or Plasma

502

2933

1.80

30.63

2.0

2.3

nmol/l

344.4

383.1

3.66

462

2703

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3611

32567

1.58

30.21

5.0

4.4

mu/l

1.8

2.4

2.91

3351

30020

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

166

4.45

29.64

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

166

4.45

29.64

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

4071

37940

1.89

29.57

18.6

11.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

166

4.39

28.74

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

166

4.39

28.74

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

166

4.39

28.74

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

166

4.39

28.74

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

220

980

2.31

28.52

1.2

1.3

titre

522.0

1015.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

118

384

3.13

28.46

2.9

2.2

—

(3025941) Bacteria identified in Stool by Culture

340

1795

1.97

28.36

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1445

11079

1.45

27.56

2.6

3.8

mmol/l

2.3

2.4

1.46

1295

9827

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

386

2146

1.87

27.55

2.4

2.3

au/ml

23.8

26.1

0.08

150

(3007461) Platelets [#/volume] in Blood

4296

40974

2.54

27.18

34.5

17.5

e9/l

258.5

252.0

8.53

4263

39808

(3024731) MCV [Entitic volume]

4296

41009

2.51

26.49

34.3

17.4

92.2

90.8

76.25

4279

40383

(3035941) MCH [Entitic mass]

4296

41009

2.51

26.49

34.2

17.4

30.6

30.3

28.70

4279

40382

(3026361) Erythrocytes [#/volume] in Blood

4296

41016

2.50

26.36

34.5

17.4

e12/l

4.5

22.54

4254

39751

(3000963) Hemoglobin [Mass/volume] in Blood

4296

41024

2.50

26.20

34.6

17.5

g/l

136.2

137.1

4.24

4276

40390

(3010813) Leukocytes [#/volume] in Blood

4296

41025

2.49

26.18

34.5

17.5

e9/l

6.9

6.6

15.17

4256

39748

(3052851) Hemolysis interference index of Serum or Plasma

198

875

2.32

26.15

2.4

3.1

—

(40768797) Stomach Pathology biopsy report

673

4435

1.61

26.02

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

352

1953

1.87

25.23

1.3

au/ml

55.1

49.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

552

3487

1.67

25.22

3.1

4.8

u/l

243.3

245.1

0.08

521

3313

(3035947) Staphylolysin Ab [Units/volume] in Serum

106

5.05

25.12

1.1

iu/ml

2.8

4.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

251

1243

2.08

24.98

1.5

1.7

g/l

1.6

1.5

1.16

210

1058

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

711

4809

1.57

24.49

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

290

3.25

24.12

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1038

2.16

24.03

1.7

2.4

g/l

4.2

3.7

2.93

146

740

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1038

2.16

24.03

1.7

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1038

2.16

24.03

1.7

2.4

g/l

7.7

7.2

3.12

153

777

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

495

3137

1.65

22.20

3.3

3.1

—

(3002032) Base excess in Venous blood by calculation

456

2832

1.68

22.11

3.9

3.8

mmol/l

2.3

2.0

1.09

370

2288

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

938

6904

1.45

21.22

1.8

1.6

pmol/l

87630629.1

24781472.5

0.78

768

5823

(3021447) Carbon dioxide [Partial pressure] in Venous blood

452

2840

1.66

20.92

3.9

3.7

kpa

5.9

5.8

0.11

444

2760

(3022621) pH of Urine by Test strip

336

1948

1.78

20.81

3.4

2.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

229

1182

1.99

20.34

2.2

2.0

ug/l

1.8

2.0

0.12

203

1080

(3026389) Candida sp identified in Specimen by Organism specific culture

112

427

2.66

20.33

1.3

1.4

—

(3044889) 12 lead EKG panel

2810

24860

1.36

20.04

3.6

3.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

262

1423

1.89

20.02

2.7

0.7

0.64

253

1363

(3024354) Oxygen [Partial pressure] in Venous blood

378

2296

1.71

19.85

3.6

3.1

kpa

4.5

4.7

0.79

371

2227

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3900

36581

1.55

19.40

4.9

4.2

mmol/l

4.7

4.8

5.38

3662

34181

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

362

2191

1.71

19.25

1.6

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1297

10253

1.37

19.17

4.0

3.9

mg/mmol

12.1

8.2

1.45

849

6506

(3017354) Segmented neutrophils/100 leukocytes in Blood

295

2.95

19.04

2.9

3.9

58.5

59.1

0.07

187

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

974

2.04

18.63

1.7

2.4

g/l

3.2

3.0

1.86

147

764

(3044640) Blood type and Crossmatch panel - Blood

1281

10158

1.37

18.42

2.5

2.3

—

(3001729) Color of Synovial fluid

30.15

18.31

2.1

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

193

974

2.03

18.28

1.8

2.3

g/l

10.9

10.3

0.78

167

820

(3022217) INR in Platelet poor plasma by Coagulation assay

559

3821

1.53

17.99

20.8

20.4

inr

1.2

1.3

0.82

543

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3759

35112

1.46

17.84

4.4

3.7

mmol/l

1.4

1.3

13.01

3492

32463

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

176

868

2.07

17.75

1.8

2.4

g/l

0.9

1.0

0.12

151

762

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

117

491

2.42

17.45

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

319

1919

1.71

17.33

3.9

3.4

g/l

129.5

130.5

0.33

314

1878

(3005322) IgE [Units/volume] in Serum or Plasma

330

2008

1.70

17.18

1.3

1.2

u/ml

210.0

225.9

0.12

308

1858

(3014051) Protein [Presence] in Urine by Test strip

137

622

2.24

17.06

2.2

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

125

547

2.32

16.98

1.4

1.7

g/l

0.6

0.8

1.06

416

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2631

23319

1.32

16.97

3.0

2.9

—

(3022145) Colonoscopy Study observation

557

3850

1.51

16.96

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

192

1000

1.96

16.65

1.5

1.6

titre

378.0

211.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3756

35199

1.44

16.36

4.6

4.2

mmol/l

6.0

5.9

7.61

3457

32394

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3859

36371

1.47

16.09

4.8

4.1

mmol/l

1.4

1.5

5.38

3600

33816

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

157

773

2.07

15.93

1.8

2.4

g/l

0.0

1.01

143

711

(3012095) Magnesium [Moles/volume] in Serum or Plasma

737

5441

1.43

15.91

2.7

3.6

mmol/l

0.8

1.63

697

5109

(3020961) Endomysium IgA Ab [Titer] in Serum

259

1527

1.74

15.12

1.1

titre

23.0

224.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

390

2555

1.58

15.09

3.3

2.5

ml/min/173m2

67.7

69.0

0.24

166

926

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

119

537

2.25

15.08

1.1

1.2

—

110.7

—

(3009508) Creatinine [Moles/volume] in Urine

1289

10483

1.32

15.03

3.0

3.1

mmol/l

7.9

0.07

1070

8892

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

124

3.74

15.01

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

238

1374

1.77

14.95

1.6

1.9

u/l

40.2

39.4

0.28

223

1222

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3921

37175

1.47

14.80

5.2

4.6

mmol/l

2.8

5.38

3649

34535

(3015235) Bicarbonate [Moles/volume] in Capillary blood

147

727

2.06

14.77

3.1

3.2

mmol/l

25.0

0.02

122

641

(3012516) Albumin [Mass/volume] in Urine

1206

9745

1.33

14.64

3.1

3.2

mg/l

474.3

422.5

0.13

770

6117

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

298

1850

1.65

14.37

3.3

kpa

5.2

0.03

271

1722

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

147

3.43

14.36

1.2

1.5

u/l

5.0

6.2

0.97

124

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

334

2.54

14.12

1.2

u/l

58.8

68.6

0.68

215

(3003458) Phosphate [Moles/volume] in Serum or Plasma

569

4103

1.44

13.85

4.8

5.9

mmol/l

1.0

0.11

548

3847

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

474

3302

1.49

13.78

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

765

5821

1.38

13.66

2.5

3.2

mmol/l

2.4

0.33

675

5131

(3009015) Lactate [Moles/volume] in Synovial fluid

+∞

13.55

1.1

0.0

mmol/l

3.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

160

842

1.93

13.51

2.2

3.9

mg/l

83.4

119.3

0.20

121

686

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

157

821

1.95

13.51

2.2

3.8

ratio

2.4

3.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

160

843

1.93

13.47

2.2

3.9

mg/l

79.9

53.0

0.32

122

690

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

142

723

2.00

13.20

1.8

2.3

g/l

0.0

0.00

129

663

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

153

800

1.95

13.18

1.8

2.2

g/l

37.6

38.1

0.40

131

699

(3009343) pH of Capillary blood

290

1829

1.63

13.14

3.3

7.4

0.38

216

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

140

717

1.98

12.81

1.8

2.3

g/l

0.0

0.00

129

663

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

470

3315

1.47

12.81

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

3600

33840

1.34

12.54

24.2

13.0

39.4

40.3

5.86

2512

25619

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

452

3180

1.47

12.47

2.3

g/l

0.2

0.13

423

2986

(3021901) Oxygen saturation in Capillary blood

111

531

2.12

12.24

2.7

—

(21494755) Public health laboratory ask at order entry panel

290

4372

0.64

12.04

1.3

1.4

—

(4062490)

331

2.41

11.94

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2718

24721

1.26

11.84

3.5

3.0

u/l

57.1

47.0

5.73

2542

23242

(3024139) IgG subclass 3 [Mass/volume] in Serum

328

2.40

11.71

1.3

1.4

g/l

0.4

0.12

224

(3028626) Oxygen [Partial pressure] in Capillary blood

123

622

2.01

11.70

2.8

kpa

7.9

8.1

0.75

113

580

(3028192) IgG subclass 2 [Mass/volume] in Serum

329

2.40

11.63

1.3

g/l

3.2

3.0

0.27

226

(3027135) IgG subclass 1 [Mass/volume] in Serum

329

2.40

11.63

1.3

g/l

6.6

6.9

0.26

224

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

275

1773

1.59

11.39

3.2

mmol/l

1.9

1.8

0.15

197

1319

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

455

2.16

11.27

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

105

3.55

11.27

2.6

3.4

46.5

54.1

1.26

(3014576) Chloride [Moles/volume] in Serum or Plasma

549

4077

1.40

11.22

6.5

7.4

mmol/l

104.1

104.5

1.68

539

3994

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1134

9366

1.28

11.15

1.7

1.6

mmol/l

1.5

1.4

4.55

948

7841

(40760888) Immunoglobulin light chains.free panel - Serum

124

643

1.96

11.00

2.0

4.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

520

2.06

10.98

1.3

1.9

—

(3013637) Mi-2 Ab [Presence] in Serum

4.20

10.80

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.20

10.80

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.20

10.80

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.20

10.80

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

248

1582

1.60

10.76

2.4

2.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

530

3941

1.39

10.73

2.9

umol/l

9.2

8.4

0.23

453

3457

(3008757) Leukocyte morphology finding [Identifier] in Blood

311

2.37

10.68

2.2

4.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

443

2.12

10.42

1.2

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

328

2.31

10.35

1.2

1.3

titre

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1284

1.65

10.31

1.6

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

121

640

1.92

10.16

2.0

2.1

g/l

131.2

131.3

0.01

445

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

207

2.63

9.89

1.5

u/l

8.4

5.5

0.68

(42529406) Shigella sp [Presence] in Stool by Culture

154

887

1.76

9.85

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

785

6271

1.31

9.82

3.7

3.4

ng/l

356.8

661.2

0.93

561

4681

(3047007) Chlamydophila sp Ab [Presence] in Serum

462

2.06

9.73

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

153

883

1.76

9.73

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

722

1.84

9.70

1.4

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

320

2215

1.48

9.58

3.7

ng/l

81.6

88.5

0.83

271

1928

(3003327) Ova and parasites identified in Stool by Light microscopy

178

1079

1.68

9.48

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

207

1308

1.61

9.37

4.0

6.0

1.5

1.7

1.86

194

1225

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

876

1.74

9.17

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

709

1.81

9.05

1.4

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1058

8856

1.26

9.01

4.3

3.9

91.5

91.6

0.05

1030

8632

(1616796) Gas panel - Central venous blood

123

683

1.82

8.93

3.0

3.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

595

4632

1.33

8.91

1.7

1.8

1.6

1.4

4.26

504

4143

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

2.89

8.84

2.1

3.5

—

(40767503) Oxygen content in Capillary blood by calculation

118

649

1.84

8.83

2.5

2.2

16.8

16.7

0.17

308

(3002619) Bacteria identified in Specimen by Culture

4.48

8.82

1.5

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

410

2.04

8.53

1.3

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

123

694

1.79

8.49

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

168

1034

1.65

8.48

1.9

2.4

ug/l

339.8

798.8

1.10

152

986

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

129

741

1.76

8.39

1.3

2.0

nmol/l

0.9

0.8

1.01

112

623

(3037756) Immunofixation for Serum or Plasma

100

533

1.90

8.28

1.4

1.9

—

(3016502) Oxygen saturation in Arterial blood

421

3161

1.37

7.99

7.1

8.6

95.4

95.8

0.85

409

3047

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

194

2.49

7.96

1.6

1.4

u/ml

20.7

17.1

0.21

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

166

1036

1.63

7.95

2.3

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

199

1299

1.56

7.89

4.4

6.1

0.8

0.9

2.67

188

1220

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

142

853

1.69

7.89

1.2

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

472

3617

1.34

7.85

6.5

8.0

kpa

12.4

12.7

0.69

455

3461

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

472

3618

1.34

7.83

6.5

8.0

kpa

5.3

5.1

2.38

456

3456

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

178

1136

1.59

7.79

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

144

872

1.67

7.77

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

190

1233

1.57

7.74

1.9

2.0

—

(36660697) Celiac disease serology panel - Serum

353

2589

1.39

7.74

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

582

1.82

7.72

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

148

905

1.66

7.70

1.5

1.4

ug/g

273.3

261.6

0.30

540

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

247

1702

1.48

7.60

1.7

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

107

600

1.80

7.58

1.7

1.6

—

(40768804) Tissue Pathology biopsy report

1639

14562

1.20

7.52

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

353

2604

1.39

7.48

2.2

ug/l

5.0

8.7

5.96

305

2323

(1617658) Protocol used for examination of sentinel lymph nodes

355

0.20

7.45

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

253

1769

1.46

7.24

1.6

1.4

—

(3017569) Oxygen content in Arterial blood

133

2.72

7.17

1.7

2.5

—

(3003396) Base excess in Arterial blood by calculation

466

3613

1.32

7.14

6.8

8.0

mmol/l

1.3

1.0

0.76

380

2847

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

231

2.27

7.04

1.2

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

983

1.60

7.00

1.2

—

(3000991) Gas panel - Venous blood

351

2617

1.37

6.97

7.3

8.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

234

1628

1.46

6.89

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

419

3226

1.33

6.75

2.9

2.5

u/l

36.5

53.8

0.59

367

2771

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

698

1.69

6.73

2.6

6.4

iu/ml

172.2

734.1

—

102

(3005011) Chlamydia sp Ab [Titer] in Serum

4.70

6.68

1.3

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

427

1.89

6.67

1.4

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

174

2.43

6.67

1.2

u/l

14.1

18.3

0.49

148

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

169

2.44

6.58

1.4

1.3

titre

94.0

61.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

366

2777

1.35

6.51

6.5

7.5

mmol/l

1.4

1.3

0.27

350

2676

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

104

608

1.73

6.45

2.2

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

527

1.76

6.14

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

181

2620

0.68

6.13

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

329

1.96

6.00

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

336

1.95

6.00

1.3

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

818

1.59

5.89

1.1

—

(3022313) Gas panel - Capillary blood

193

1338

1.46

5.83

3.5

3.3

—

(3000492) Spirometry study

429

3382

1.30

5.83

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

391

3050

1.31

5.75

1.8

1.9

—

(4010399)

305

2295

1.35

5.75

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

420

1.82

5.74

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

226

2.14

5.71

1.6

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

181

2.28

5.70

1.2

u/l

67.8

87.7

1.35

158

(40768793) Breast Pathology biopsy report

902

0.48

5.67

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1484

0.60

5.56

1.5

1.7

mg/l

3.9

3.5

0.28

995

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.14

5.46

1.2

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

251

2.04

5.43

1.1

—

(3044927) Protein electrophoresis panel - Urine

245

2.05

5.39

1.3

1.2

—

(44813793)

225

2.10

5.38

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

431

3440

1.28

5.33

1.8

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

468

1.74

5.31

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

305

3955

0.75

5.29

1.8

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

2.09

5.23

1.7

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

2.60

5.21

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

615

5129

1.23

5.19

1.8

2.2

30.1

29.8

0.66

598

4985

(3013139) Helicobacter pylori Ag [Presence] in Stool

294

2236

1.34

5.19

1.2

—

(3042631) Mycobacterium sp identified in Specimen

421

1.77

5.12

2.5

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

885

7663

1.19

5.07

2.5

2.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

258

1.99

5.06

1.4

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

258

1.99

5.06

1.4

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

258

1.99

5.06

1.4

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

589

1.64

5.06

1.1

—

(3037121) Protein [Mass/volume] in Urine

157

1079

1.47

5.01

2.6

3.3

g/l

0.3

0.06

475

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

546

1.66

4.96

1.5

—

(3019225) pH of Specimen

380

3018

1.28

4.90

3.3

4.0

—

(3011412) CD3 cells [#/volume] in Blood

312

1.87

4.83

1.7

2.7

e9/l

1.1

0.07

182

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

292

1.89

4.77

3.2

4.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

446

1.72

4.75

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

227

1689

1.36

4.65

8.5

10.1

mmol/l

24.7

24.3

1.10

210

1594

(3015183) Erythrocyte sedimentation rate

166

2.18

4.58

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.77

4.53

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

2.31

4.51

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

370

2964

1.27

4.47

7.6

9.0

g/l

122.7

122.4

0.09

359

2849

(3012501) Base excess in Blood by calculation

111

732

1.53

4.37

3.8

3.7

mmol/l

2.4

0.04

495

(3035320) C reactive protein [Mass/volume] in Body fluid

210

2.01

4.35

2.8

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

331

1.79

4.34

1.2

—

(40768800) Prostate Pathology biopsy report

686

0.49

4.28

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.62

4.20

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

166

2.12

4.18

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

115

2.36

4.15

2.0

2.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

248

1919

1.31

3.95

7.1

7.8

mmol/l

25.1

24.6

1.18

231

1793

(3014007) Fractional oxyhemoglobin in Arterial blood

253

1965

1.30

3.92

8.9

9.9

94.1

94.0

0.06

253

1960

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.26

3.90

2.3

11.2

umol/l

0.5

0.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

306

1.77

3.88

1.4

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

242

1.87

3.82

1.6

2.1

11.4

14.4

1.18

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

1.98

3.81

1.2

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

322

0.31

3.79

5.2

17.0

nmol/l

1060.9

1424.1

—

315

(3017817) Protein [Mass] in Urine collected for unspecified duration

265

1.82

3.76

2.0

2.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

287

1.79

3.76

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

596

1.54

3.75

1.1

iu/ml

33.8

17085.5

0.53

137

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

128

2.20

3.69

1.4

1.6

umol/l

226.3

154.3

0.17

(3049717) Cytology report of Urine Cyto stain

150

1087

1.39

3.69

2.4

2.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

317

0.31

3.69

4.5

12.3

nmol/l

591.4

831.3

—

303

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

1.99

3.67

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

312

1.74

3.65

1.2

1.9

—

(3022806) Fractional oxyhemoglobin in Capillary blood

403

1.65

3.65

1.9

1.7

90.4

90.0

0.32

396

(3010421) pH of Blood

122

855

1.44

3.62

3.7

3.8

7.4

0.11

110

714

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.71

3.60

1.2

1.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

285

1.76

3.55

1.7

2.5

48.4

39.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

345

2821

1.24

3.54

6.7

7.9

mmol/l

10.2

9.1

1.93

333

2694

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

2.29

3.51

1.1

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

288

1.74

3.44

1.2

titre

182.0

195.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

465

1.58

3.43

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

189

1439

1.33

3.42

3.3

4.0

mmol/l

24.3

24.2

0.24

168

1302

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

610

1.50

3.40

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

610

1.50

3.40

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

335

1.68

3.37

1.1

—

(3019060) Gas panel - Arterial blood

254

2016

1.28

3.37

4.7

5.5

—

(4211845)

154

2.02

3.34

6.4

2.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

2.02

3.34

1.1

miu/ml

1249.6

1566.6

1.09

154

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1227

11201

1.13

3.32

4.2

4.5

ug/l

2.0

3.0

2.33

1087

10158

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

656

1.47

3.28

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

170

1.95

3.23

1.2

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

301

2452

1.24

3.22

3.1

2.8

ng/l

198.0

171.9

0.38

263

2226

(3051387) C reactive protein [Mass/volume] in Capillary blood

105

734

1.44

3.20

4.2

3.1

mg/l

22.4

26.8

0.59

453

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

250

1.77

3.19

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

110

2.19

3.18

1.5

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

207

1.84

3.16

1.1

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

531

1.52

3.16

1.5

2.9

u/ml

1202.8

1032.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

296

1.70

3.15

1.9

2.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

172

1.93

3.13

1.2

1.5

ug/l

7.7

8.7

0.24

148

(3051101) Glucose [Moles/volume] in Cord blood

2.81

3.08

2.4

6.8

—

(3020891) Body temperature

161

1218

1.33

3.08

5.1

4.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.83

3.07

1.1

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.68

3.05

1.6

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

153

1154

1.34

2.99

3.4

mmol/l

24.6

24.8

0.65

136

1058

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

168

1.91

2.99

1.3

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

372

1.59

2.94

6.4

6.9

mg/l

12.5

11.8

0.48

344

(3000012) Reticulocyte production index

155

1.94

2.94

1.5

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

632

1.45

2.91

1.2

u/ml

333.1

278.3

0.74

407

(3028433) Virus identified in Specimen by Culture

102

2.16

2.86

1.1

1.2

—

(3036603) Volume of Urine

244

1.73

2.86

1.7

2065.0

1913.6

0.15

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

2.12

2.84

1.3

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

329

1.62

2.83

5.7

26.1

mmol/l

8.2

7.6

0.42

277

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

289

2381

1.23

2.82

1.2

iu/ml

115.4

144.8

0.66

111

903

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

1.87

2.80

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

679

1.42

2.79

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

158

1.90

2.79

1.3

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

158

1.90

2.79

1.3

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

158

1.90

2.79

1.3

2.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.92

2.77

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.23

2.77

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.27

2.76

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.17

2.76

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

217

1.76

2.75

1.2

1.3

u/ml

0.0

0.5

3.17

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.86

2.75

1.6

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

2.37

2.72

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

196

1.79

2.71

1.0

—

(3023410) Appearance of Cerebral spinal fluid

341

1.59

2.70

1.4

1.7

—

(3006462) Nitrate [Presence] in Urine

139

1.95

2.69

7.0

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

449

3874

1.18

2.68

7.3

6.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

112

2.06

2.66

1.1

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

183

0.33

2.66

4.0

2.0

nmol/l

129.8

152.1

—

155

(21494434) Karyotype in Bone marrow

265

1.67

2.65

1.2

—

(3006270) Folate [Moles/volume] in Blood

265

1.67

2.65

1.2

1.1

nmol/l

364.5

376.1

0.14

236

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

375

1.55

2.63

1.1

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

118

877

1.35

2.59

1.1

u/ml

1.3

7.1

1.90

130

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

140

1068

1.32

2.58

1.2

1.3

miu/ml

158.1

215.8

0.98

511

(3026480) Teichoate Ab [Titer] in Serum

4.00

2.56

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

158

1.84

2.47

1.3

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

144

1.88

2.45

1.9

2.4

—

(3016018) Differential panel - Cerebral spinal fluid

374

1.53

2.45

1.3

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.67

2.45

1.4

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

383

1.52

2.42

1.1

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

673

1.39

2.42

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

724

1.38

2.42

3.2

3.1

umol/l

35.8

34.6

0.22

618

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

683

1.38

2.40

1.3

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.42

2.36

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.42

2.36

1.1

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

251

1.64

2.36

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.12

2.36

1.1

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

443

1.47

2.35

1.2

1.3

nmol/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

108

806

1.35

2.34

1.8

pmol/l

195.8

205.9

0.52

765

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.09

2.32

1.1

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

594

1.40

2.32

1.3

1.5

u/ml

111.7

115.3

0.12

124

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

126

1.91

2.30

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

316

1.56

2.29

2.8

3.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

215

1.68

2.28

1.9

2.9

e6/l

358.1

519.3

1.89

180

(4034850)

147

1151

1.29

2.28

11.7

8.2

—

(40768441) Liver Pathology biopsy report

285

1.58

2.27

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

141

1.85

2.27

1.4

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.34

2.21

1.7

2.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.56

2.21

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

118

901

1.32

2.21

2.7

2.8

mg/l

1.5

1.4

0.62

100

843

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

202

1.69

2.20

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

121

1.91

2.20

1.2

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

121

1.91

2.20

1.2

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

1.91

2.20

1.2

2.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

172

1.75

2.20

1.9

2.6

u/ml

1072.1

1482.5

0.42

172

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

157

1961

0.79

2.17

2.6

3.8

u/ml

34.6

53.5

0.89

152

1888

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

460

1.44

2.15

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

108

1.95

2.15

1.9

2.1

25.2

28.6

0.55

101

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.17

2.14

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

116

1.90

2.10

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.20

2.09

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.08

2.06

1.7

2.5

—

(3000034) Microalbumin [Mass/volume] in Urine

333

1.51

2.06

2.6

2.8

mg/l

19.5

55.5

1.07

237

(3023419) Bacteria identified in Sputum by Culture

392

1.46

2.01

1.6

2.4

—

(44790047)

343

1.49

2.01

1.7

1.5

—

(44790048)

343

1.49

2.01

1.7

1.5

—

(44790049)

343

1.49

2.01

1.7

1.5

—

(44806118)

343

1.49

2.01

1.7

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

751

1.33

1.97

1.4

1.5

e6/l

1111.6

1407.1

0.19

607

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

397

3485

1.15

1.95

1.4

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

229

0.44

1.95

1.0

ng/l

222.0

334.1

—

165

(3051651) Icteric interference index of Serum or Plasma

210

1.62

1.94

2.9

3.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

488

1.40

1.92

1.1

1.0

u/ml

2.5

0.00

254

(3020650) Glucose [Presence] in Urine

1.92

1.90

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

567

0.65

1.88

4.0

5.5

umol/l

371.4

378.9

0.10

485

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

751

1.31

1.84

1.3

1.5

e6/l

26.3

17.7

0.29

576

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.53

1.83

1.2

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

376

1.44

1.82

1.1

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

452

1.40

1.80

2.6

3.0

nmol/l

0.9

0.8

0.21

337

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

235

0.47

1.80

1.0

ng/l

19.8

46.6

—

165

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.27

1.80

3.1

2.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.05

1.80

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

108

843

1.29

1.78

1.3

1.4

mg/l

485.9

503.6

0.18

102

797

(3000285) Sodium [Moles/volume] in Blood

2.34

1.77

1.1

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

233

0.47

1.77

1.0

ng/l

1006.5

708.4

—

163

(3006245) CD3-CD19+ cells/100 cells in Blood

109

1.84

1.77

2.0

2.1

9.8

11.2

0.32

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

446

1.40

1.76

1.5

1.4

pmol/l

356.9

284.8

0.81

333

(3048879) Bone marrow aspiration report

2.03

1.74

1.3

2.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.03

1.74

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

250

2139

1.18

1.74

2.6

3.5

pmol/l

4.5

0.05

220

1926

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

733

1.30

1.72

1.2

1.3

mmol/l

3.6

3.8

0.78

687

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.92

1.72

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.88

1.70

1.1

1.2

96.6

84.2

—

(3036489) Thrombin time

157

1290

1.23

1.69

1.7

2.0

23.1

21.5

0.83

133

1128

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

126

1011

1.25

1.68

1.9

2.2

u/l

4537.7

4935.8

0.05

408

(3020491) Glucose [Moles/volume] in Blood

251

1.52

1.67

2.0

1.6

mmol/l

7.0

6.7

0.26

164

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.58

1.66

5.5

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

806

0.73

1.65

1.4

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.91

1.59

1.1

u/ml

2.0

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

136

1.69

1.58

2.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

136

1.69

1.58

2.3

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

103

814

1.27

1.58

2.0

2.4

ug/min

144.6

125.0

0.17

498

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.20

1.56

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

508

1.34

1.56

1.7

—

(3024928) Oxygen saturation in Venous blood

666

1.30

1.55

2.5

3.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1122

1.23

1.54

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

373

1.40

1.53

1.1

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

200

1.55

1.53

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

198

1683

1.18

1.52

1.4

1.3

iu/l

30.8

32.2

0.24

176

1449

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

177

1.59

1.51

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.86

1.50

1.3

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

291

1.45

1.50

1.1

1.3

mmol/l

14.0

11.7

1.02

(3002256) Pathology report gross observation

514

4674

1.11

1.49

1.3

—

(3019977) pH of Arterial blood

170

1.59

1.48

4.2

3.4

7.4

0.03

(3005988) Vibrio sp identified in Specimen by Organism specific culture

376

1.39

1.48

1.1

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.13

1.44

1.6

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

125

1025

1.23

1.42

2.9

3.3

u/ml

0.3

0.10

567

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

229

1.49

1.41

1.5

2.1

u/field

2.6

2.0

0.28

(3006653) Thiamine [Moles/volume] in Blood

149

1.61

1.40

1.3

1.2

nmol/l

142.6

131.8

0.70

149

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.18

1.39

1.9

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

137

0.44

1.39

1.0

1.6

umol/l

34.8

29.7

—

129

(3027923) C peptide [Moles/volume] in Serum or Plasma

181

1.55

1.39

1.8

1.2

nmol/l

1.5

1.1

0.87

136

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

134

1.64

1.38

3.0

4.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

111

902

1.24

1.38

5.0

4.3

mmol/l

3.9

0.01

105

850

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

203

1750

1.17

1.35

8.4

11.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

310

2757

1.13

1.33

2.1

nmol/l

13.0

13.3

0.37

267

2479

(3011985) Renin [Units/volume] in Plasma

479

1.32

1.33

1.5

1.4

mu/l

85.4

55.4

0.47

429

(3003181) Sodium [Moles/volume] in Urine

532

1.30

1.32

1.3

mmol/l

67.4

65.4

0.13

419

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

376

1.36

1.32

1.1

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

1.55

1.31

1.5

2.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

1.31

0.0

1.8

—

(1002224) Polysomnography panel

197

1700

1.17

1.30

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

525

1.30

1.29

1.3

1.2

u/ml

3.3

3.8

0.09

171

(3050794) Legionella sp Ab [Presence] in Serum

2.36

1.29

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.72

1.27

1.1

95.4

88.7

—

(3004451) EKG impression Narrative

138

1.60

1.26

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

340

0.65

1.25

1.1

1.3

ug/l

3.0

3.8

0.30

285

(1761868) Lipid panel - Serum or Plasma

1514

14512

1.07

1.24

3.1

2.7

—

(3044290) Cell count panel - Cerebral spinal fluid

699

1.25

1.22

1.3

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.91

1.22

1.2

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

1.67

1.22

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.04

1.22

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.04

1.22

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.04

1.22

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.04

1.22

1.0

1.1

—

(4035726)

303

3381

0.89

1.21

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

101

1.69

1.19

1.1

1.4

—

(4133840)

1.75

1.18

1.5

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

104

856

1.22

1.18

1.6

1.9

iu/l

3.3

4.3

1.11

337

(4146454)

324

1.36

1.17

2.7

2.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

125

1.60

1.17

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

139

1178

1.19

1.17

1.7

mu/l

249.8

306.2

2.89

126

1083

(3017704) Immunofixation for Urine

149

1.55

1.17

1.2

1.9

—

(3004775) Volume in Urine collected for unspecified duration

274

1.39

1.15

2.0

2.4

758.7

617.8

0.92

184

(44806420)

1.73

1.15

2.2

2.3

—

(3014271) Vancomycin [Susceptibility]

118

1.61

1.14

3.3

2.8

—

(3011288) Drugs identified in Urine by Screen method

104

860

1.21

1.14

1.8

2.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

1.57

1.14

3.7

2.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

1.14

0.0

7.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

225

1.43

1.12

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

432

3961

1.10

1.11

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

380

1.32

1.10

1.7

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

121

1020

1.19

1.09

2.2

2.6

g/l

3.8

3.6

0.72

113

971

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

201

1.45

1.09

1.2

1.1

ratio

1.1

0.07

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.38

1.09

1.2

1.1

mmol/l

7.6

8.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.38

1.09

4.8

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

536

0.74

1.08

1.5

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.19

1.08

1.0

1.1

—

(4281824)

444

0.72

1.07

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.76

1.06

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

532

0.75

1.03

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.63

1.03

1.3

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

238

1.39

1.02

2.0

3.1

e6/l

593.4

690.7

0.27

103

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

539

1.25

0.98

1.1

—

(3003338) MCHC [Mass/volume]

3232

31808

1.06

0.97

30.0

15.2

g/l

331.9

333.0

9.68

3220

31585

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

128

1099

1.17

0.96

1.8

2.2

90.4

91.1

0.11

121

1026

(3006922) Hepatitis E virus Ab [Presence] in Serum

258

1.36

0.96

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

149

1.48

0.95

1.1

3.3

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.95

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.95

0.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

311

1.32

0.94

2.2

2.0

mg/l

30.9

20.4

0.44

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

678

1.21

0.94

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.89

0.94

2.3

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

142

1.48

0.92

1.2

2.3

ug/l

346.9

23.2

0.47

129

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

639

0.80

0.87

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.87

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

115

990

1.17

0.86

2.3

2.4

187.4

192.1

0.23

107

945

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

638

0.80

0.86

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

209

1875

1.12

0.86

1.7

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

193

1724

1.12

0.86

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

1020

9767

1.06

0.85

1.4

—

(3016750) Collection duration of Urine

187

1.39

0.85

1.8

2.4

min

524.7

494.8

0.59

146

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

636

0.80

0.84

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

1.63

0.84

1.7

2.2

e6/l

122.5

168.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

635

0.80

0.84

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

154

1.43

0.83

1.2

1.9

u/field

1.2

3.8

1.22

111

(3010726) Horse dander IgE Ab [Units/volume] in Serum

588

0.80

0.81

1.1

u/ml

0.3

1.6

—

133

(3047181) Lactate [Moles/volume] in Blood

117

1016

1.16

0.80

4.6

7.4

mmol/l

1.3

0.12

104

890

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.73

0.79

1.1

—

6.9

—

(3045788) Cell count panel - Pleural fluid

303

1.29

0.79

1.5

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

147

0.61

0.79

2.1

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

190

1.37

0.78

2.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

552

0.80

0.78

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.08

0.74

1.0

1.6

—

43.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

114

996

1.15

0.74

1.4

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

133

1.43

0.73

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.64

0.73

2.8

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

108

1.48

0.73

1.9

3.7

—

(3012441) Differential panel - Pleural fluid

325

1.26

0.73

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

165

1479

1.12

0.72

1.6

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.80

0.72

1.6

1.5

ng/l

169.4

125.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

654

1.18

0.71

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.55

0.71

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

353

1.25

0.71

1.5

1.3

e6/l

21642.3

64672.7

1.49

212

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.75

0.71

2.3

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.75

0.71

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

686

0.83

0.71

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.92

0.70

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

750

0.84

0.70

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

432

0.79

0.69

1.1

u/ml

0.7

0.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.51

0.69

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.85

0.68

1.2

umol/24h

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

118

1334

0.88

0.68

1.9

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

420

1.22

0.67

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.79

0.66

1.4

2.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

241

1.29

0.65

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.54

0.65

1.4

2.3

—

(44806071)

1.59

0.65

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.59

0.65

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

180

1.34

0.64

2.8

3.1

45.3

39.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

130

0.61

0.63

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

426

4016

1.07

0.63

4.4

4.2

31.3

32.0

0.64

318

2747

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

243

1.28

0.62

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.52

0.62

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.55

0.62

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.61

1.8

3.2

u/field

0.2

0.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

182

1.32

0.61

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

244

1.27

0.61

1.1

1.0

—

(4094501)

112

995

1.13

0.60

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.3

—

319.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

620

1.16

0.60

1.5

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

477

0.82

0.60

1.1

u/ml

1.3

4.0

—

169

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.54

0.59

1.1

1.5

—

172.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

343

0.79

0.58

1.7

1.5

g/l

1.0

0.35

343

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.48

0.57

3.5

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

561

0.84

0.57

5.9

2.6

13.3

13.1

0.63

553

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

408

0.81

0.56

1.7

1.5

—

(4015189)

1.51

0.56

3.2

2.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.46

0.56

23.1

8.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

200

2165

0.92

0.54

1.8

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

957

1.12

0.53

1.4

1.3

u/l

10.0

10.7

0.21

788

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

331

1.21

0.53

1.1

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

497

1.17

0.53

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

227

0.75

0.53

7.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

507

1.17

0.52

1.3

1.2

u/ml

6.2

4.6

0.33

236

(3023199) Leukocytes [#/volume] in Pleural fluid

388

1.19

0.51

1.5

1.4

e6/l

3074.1

2134.6

0.29

288

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

401

0.82

0.50

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

288

2710

1.07

0.49

1.6

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

550

0.85

0.48

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

211

0.76

0.47

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

106

1172

0.90

0.47

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

264

1.21

0.45

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

320

0.81

0.45

5.1

5.5

u/ml

35.7

83.7

0.99

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

231

0.78

0.44

1.2

1.3

—

(3035880) pH of Pleural fluid

166

1.27

0.43

1.6

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.56

0.42

1.4

1.1

—

(3042517) Benzodiazepines panel - Urine

1.56

0.42

4.0

2.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.38

0.42

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

149

1.28

0.41

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

258

1.20

0.41

1.1

1.2

mg/l

38.0

41.2

0.18

212

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

548

5687

0.96

0.41

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

3.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.4

—

(40765096) Chromosome analysis panel by Banding

105

1.33

0.41

1.4

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.33

0.40

1.0

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

882

1.10

0.40

1.1

—

(3047189) Immunofixation for 24 hour Urine

150

1.27

0.40

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.43

0.39

1.8

2.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

226

0.80

0.39

7.7

11.0

mmol/l

0.6

0.14

202

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

312

0.83

0.37

1.2

1.3

pmol/l

78.6

69.5

0.12

(40757494) Bilirubin.total [Moles/volume] in Blood

179

1.23

0.37

2.0

2.7

—

13.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

327

1.16

0.37

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

171

1.23

0.35

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.35

1.2

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.35

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

447

0.87

0.34

2.5

3.6

nmol/l

4.8

5.2

0.09

438

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

531

0.88

0.33

1.3

1.4

nmol/l

0.3

0.4

0.24

406

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

297

0.84

0.33

2.6

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

923

9031

1.03

0.31

3.7

3.9

21.6

21.8

0.10

389

4245

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.32

0.30

1.6

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

902

0.92

0.30

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

0.82

0.30

1.0

1.1

u/l

0.9

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

515

0.89

0.30

1.0

1.1

u/ml

4.0

2.7

0.23

185

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

216

0.83

0.28

1.4

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

556

1.10

0.27

1.6

2.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

730

1.08

0.27

3.0

3.6

u/ml

116.1

454.6

1.83

669

(40768446) Kidney Pathology biopsy report

128

0.78

0.26

1.5

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

125

1327

0.94

0.26

1.3

1.4

—

(4306422)

529

1.10

0.26

1.2

—

(3008295) Osmolality of Serum or Plasma

329

1.13

0.26

1.5

1.4

mosm/kgh2o

282.8

280.0

0.28

254

(3028300) Cannabinoids [Presence] in Urine

138

1307

1.06

0.25

1.4

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

137

1298

1.06

0.24

1.4

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

116

1.21

0.22

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.8

—

16.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.8

—

380.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

1.8

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.2

—

271.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3027008) Opiates [Presence] in Urine

137

1305

1.05

0.21

1.4

2.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.7

—

(3016879) Cocaine [Presence] in Urine

126

1198

1.05

0.21

1.4

2.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.21

0.0

1.0

—

208.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3018572) Chloride [Moles/volume] in Blood

747

0.94

0.19

6.2

8.6

mmol/l

104.4

105.3

0.71

671

(3011648) Oxygen content in Venous blood

260

1.12

0.19

1.9

2.3

10.0

11.5

1.29

260

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

364

3734

0.97

0.19

3.2

4.5

ug/l

12.7

32.3

1.60

299

3051

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.15

0.19

1.2

1.0

—

(3039000) Anion gap in Blood

746

0.94

0.19

6.2

8.6

mmol/l

11.1

0.03

670

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

259

0.89

0.18

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

166

1.15

0.18

1.8

1.9

—

(3042733) HLA Ab [Presence] in Serum

121

0.83

0.18

3.1

4.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.17

0.17

1.4

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

138

1.16

0.17

3.7

9.1

u/ml

—

13136.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

630

0.94

0.17

1.1

u/ml

3.9

5.4

0.23

294

(3027944) Amphetamines [Presence] in Urine

133

1281

1.04

0.15

1.4

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.81

0.14

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.14

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

314

1.08

0.14

2.3

2.1

umol/l

9.0

6.8

0.32

231

(40765089) Chromosome analysis panel - Blood by G-banded

0.83

0.13

1.0

1.1

—

(4268621)

354

1.07

0.13

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

110

0.82

0.13

1.4

2.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

1.15

0.12

7.4

7.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

702

0.95

0.12

1.1

u/ml

0.5

1.6

1.89

253

(3022493) Free Hemoglobin [Mass/volume] in Plasma

143

1.12

0.11

1.1

7.2

mg/l

66.5

63.8

0.07

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

124

1.13

0.11

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

105

1.14

0.11

1.0

—

5.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.16

0.11

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

389

1.05

0.09

2.4

2.5

—

(3044007) Cell count panel - Peritoneal fluid

116

1.12

0.09

1.7

2.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

223

1.08

0.09

1.1

—

(3024471) HLA-A [Type]

126

1.11

0.09

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.09

0.08

1.0

1.1

—

(4027681)

204

1.08

0.08

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.03

0.08

1.5

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.03

0.08

2.5

2.6

pmol/l

54.9

62.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

509

1.04

0.08

1.2

1.3

u/l

22.8

31.3

1.58

424

(3008536) Aspergillus sp Ab [Presence] in Serum

0.81

0.07

1.0

2.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.81

0.07

1.0

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.80

0.07

1.5

2.1

umol/l

14.4

17.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

601

0.96

0.07

1.1

u/ml

1.3

0.01

236

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

479

0.96

0.07

1.9

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

489

0.96

0.07

1.3

mmol/l

9.2

7.3

2.37

362

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.86

0.07

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

284

0.95

0.06

2.4

1.7

—

(3045142) Bone marrow Pathology biopsy report

365

1.04

0.06

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

314

0.96

0.05

1.5

promille

1.3

1.4

0.07

238

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.2

1.1

—

(4198724)

151

0.93

0.05

1.6

3.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

130

0.92

0.04

2.8

2.0

e6/l

357.3

6161.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

373

0.96

0.04

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

150

1.07

0.04

6.6

10.4

—

(4024509)

259

1.04

0.04

1.7

1.5

—

(3034426) Prothrombin time (PT)

131

1.07

0.03

1.2

—

(3025130) Human papilloma virus identified in Specimen

488

1.02

0.03

1.6

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

653

6554

1.00

0.03

2.8

ug/l

0.6

0.8

10.49

403

4105

(3014599) Egg white IgE Ab [Units/volume] in Serum

229

0.96

0.02

1.1

1.0

u/ml

9.0

0.8

—

(40768795) Lymph node Pathology biopsy report

359

0.97

0.02

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

163

1.04

0.01

1.4

1.5

mmol/l

9.5

8.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

203

1.03

0.01

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

353

1.02

0.01

1.3

1.7

—

(3033799) Differential panel - Peritoneal fluid

126

0.95

0.00

2.9

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

133

1323

1.01

0.00

3.5

3.9

u/ml

1119.0

4020.0

0.71

113

1166

(3028679) Herpes simplex virus Ab [Presence] in Serum

184

1.03

0.00

1.2

1.1

—

(3024932) HLA-DR beta [Type]

125

1.04

0.00

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

1.04

0.00

2.8

2.4

—

(40768806) Pleura Pathology biopsy report

355

0.99

0.00

1.6

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

154

0.97

0.00

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

143

0.98

0.00

1.1

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

143

0.98

0.00

1.1

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

197

1.02

0.00

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

584

0.99

0.00

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

451

1.00

0.00

1.4

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

581

1.00

0.00

1.2

1.1

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.99

0.00

1.9

1.5

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.6

—

6.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

220

1.00

0.00

1.1

1.0

u/ml

26.8

3.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

14.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.98

0.00

1.4

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.91

0.00

7.1

8.4

—

(40758292) HTLV I+II Ab panel - Serum

1.00

0.00

1.7

1.5

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.96

0.00

9.3

3.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.02

0.00

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

0.00

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

3340.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.90

0.00

1.3

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.95

0.00

1.1

1.4

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.3

—

87.9

—

(40757373) Influenza virus identified in Isolate

0.95

0.00

1.8

2.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.91

0.00

1.0

1.8

pmol/l

30.6

29.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.93

0.00

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

419.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.96

0.00

9.3

3.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

2.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.94

0.00

7.8

8.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PSORIARTH and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_PSORIARTH	1.301 [1.16, 1.46]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 766 out of 8776 females with M13_PSORIARTH died.

Males

Parameter	HR [95% CI]	p-value
M13_PSORIARTH	1.194 [1.08, 1.32]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1118 out of 8548 males with M13_PSORIARTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_PSORIARTH.

N-year risk	Females	Males
1	0.118%	0.209%
5	0.688%	1.217%
10	1.762%	3.225%
15	3.127%	6.311%
20	5.428%	10.426%

Relationships between endpoints

↥

Index endpoint: M13_PSORIARTH – Psoriatic arthropathies

GWS hits: 18

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Psoriatic arthropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints